INCIDENCE OF ALLERGIC FUNGAL SINUSITIS AMONG PATIENTS WITH CHRONIC RHINOSINUSITIS

Background Bacterial biofilms may explain why some patients with bacterial chronic rhinosinusitis (CRS) improve while on antibiotics but relapse after completion of the antibiotic. In the human host, biofilms exist as a community of bacteria surrounded by a glycocalyx that is adherent to a foreign body or a mucosal surface with impaired host defense. Biofilms generate planktonic, nonadherent bacterial forms that may metastasize infection and generate systemic illness. These planktonic bacteria are susceptible to antibiotics, unlike the adherent biofilm. Methods We reviewed four cases of CRS using transmission electron microscopy (TEM) to assay for typical colony architecture of biofilms. Bacterial communities surrounded by a glycocalyx of inert cellular membrane materials consistent with a biofilm were shown in two patients. Results In the two patients without biofilm, a nonbacterial etiology was discovered (allergic fungal sinusitis) in one and in the other there was scant anaerobic growth on culture and the Gram stain was negative. Culture of the material from the biofilm grew Pseudomonas aeruginosa in both patients. Pseudomonas from the biofilm showed a glycocalyx, not present in Pseudomonas cultured for 72 hours on culture media. Both patients’ symptoms with bacterial biofilms were refractory to culture-directed antibiotics, topical steroids, and nasal lavages. Surgery resulted in cure or significant improvement. Conclusion Biofilms are refractory to antibiotics and often only cured by mechanical debridement. We believe this is the first TEM documentation of bacterial biofilms in CRS in humans.

Download Full-text

Role of Fungi in Allergic Fungal Sinusitis and Chronic Rhinosinusitis

Mayo Clinic Proceedings ◽

10.1016/s0025-6196(11)64229-8 ◽

2000 ◽

Vol 75 (5) ◽

pp. 540-541

Author(s):

Jens U. Ponikau ◽

David A. Sherris ◽

Eugene B. Kern

Keyword(s):

Chronic Rhinosinusitis ◽

Fungal Sinusitis ◽

Allergic Fungal Sinusitis

Download Full-text

Nasal Polyp Cell Populations and Fungal-Specific Peripheral Blood Lymphocyte Proliferation in Allergic Fungal Sinusitis

American Journal of Rhinology and Allergy ◽

10.2500/ajra.2009.23.3356 ◽

2009 ◽

Vol 23 (5) ◽

pp. 453-460 ◽

Cited By ~ 8

Author(s):

Harshita Pant ◽

Dimitra Beroukas ◽

Frank E. Kette ◽

William B. Smith ◽

Peter J. Wormald ◽

...

Keyword(s):

T Cells ◽

Chronic Rhinosinusitis ◽

Peripheral Blood ◽

Blood Lymphocyte ◽

Lymphocyte Proliferation ◽

Inflammatory Cell ◽

Cell Populations ◽

Fungal Sinusitis ◽

Allergic Fungal Sinusitis ◽

Fungal Allergy

Background Allergic fungal sinusitis (AFS) is considered a different disease from other polypoid chronic rhinosinusitis diseases (CRS) with eosinophilic mucus (EM) termed eosinophilic mucus chronic rhinosinusitis (EMCRS). To substantiate this, studies on cellular responses to fungi and sinus mucosal inflammatory cell populations in AFS and other EMCRS diseases are required. This study was designed to examine polyp inflammatory cell populations and peripheral blood fungal–specific T-cell responses in AFS, other EMCRS subgroups (defined later), and polypoid CRS without EM. Methods A prospective study was performed. Clinical characteristics, including CRS symptoms, sinus computed tomography (CT) scans, allergy status, intraoperative endoscopy, presence of EM, and fungal culture results were used to define patient groups. Polyps and peripheral blood were examined for populations of eosinophils, lymphocytes (CD4+, CD8+ T cells, natural killer cells, and B cells), and neutrophils using immunohistochemistry, cytospin preparations and flow cytometry. Fungal-specific peripheral blood lymphocyte proliferation was examined in AFS patients, other EMCRS patients, CRS patients, and controls. Results There was no significant difference in the percentage of cell populations and fungal-specific lymphocyte proliferation between AFS and other EMCRS diseases. However, AFS and other EMCRS polyps had a higher percentage of eosinophils and CD8+ T cells whereas CRS polyps had higher CD4+ T cells. Fungal-specific lymphocyte proliferation was significantly greater in AFS and other EMCRS patients regardless of fungal allergy, whereas in CRS and controls, higher proliferation was observed in fungal-allergic individuals. Conclusion These findings question the basis for differentiating AFS from other EMCRS diseases based on fungal allergy and fungi in EM. Fungal-specific cellular response was present in AFS and other EMCRS diseases, different from that associated with fungal allergy, suggesting a nonallergic fungal immune response. Increased CD8+ T cells in EMCRS polyps signify a different type of inflammation to CRS that may be driven by CD8+ T cells.

Download Full-text

Recurrence Pattern and Complication Rate of Allergic Fungal Sinusitis: A 10-Year Tertiary Center Experience

International Journal of Otolaryngology ◽

10.1155/2020/9546453 ◽

2020 ◽

Vol 2020 ◽

pp. 1-6

Author(s):

Yazeed Alghonaim ◽

Abdulrhman Alfayez ◽

Riyadh Alhedaithy ◽

Abdullah Alsheikh ◽

Malak Almalki

Keyword(s):

Chronic Rhinosinusitis ◽

Recurrence Rate ◽

Nasal Obstruction ◽

Recurrent Disease ◽

Disease Recurrence ◽

Fungal Sinusitis ◽

Allergic Fungal Sinusitis ◽

Bilateral Disease ◽

Fungal Rhinosinusitis ◽

Allergic Fungal Rhinosinusitis

Background. Allergic fungal rhinosinusitis is a noninvasive form of highly recurrent chronic rhinosinusitis. Despite the advancement in medical and surgical strategies, recurrence in AFRS in general poses another challenging problem with reported incidence that eventually can reach more than 60%. Recognition and understanding the pattern of disease recurrence will lead to greater understanding of the disease response in our population. Method. A retrospective cohort study was performed in King Abdulaziz Medical City in Riyadh, Saudi Arabia. All patients diagnosed with chronic rhinosinusitis and underwent functional endoscopic sinus surgery from the period of January 2006 to December 2016 were reviewed. Results. 28 patients were found to have AFRS based on clinical, radiological, and microscopic examination suggestive of allergic fungal rhinosinusitis. Among these patients, 53% of them were female and 46% were male. The age ranged from 13 to 55 years, with a mean age of 31.57 years. 28.57% of the patients presented with recurrent allergic fungal sinusitis. The duration between the surgery and symptoms recurrence was around one year. Male and female patients had similar recurrence rate (50%). At first visit, 95% of the patients with nonrecurrent disease presented with nasal obstruction compared to 87.5% of the patients with recurrent disease. On the other hand, patients with recurrent disease had more nasal discharge (87.5%), postnasal drip (37.5%), facial pressure/pain (50%), headache (50%), nasal polyposis (87.5%), hypertrophy of inferior turbinate (37.5%), and proptosis (12.5%). Nasal obstruction (87.5%) and nasal polyps (87.5%) were the most common presenting symptoms for the disease recurrence. The pattern of disease recurrence in the previously unilateral disease was 18% ipsilateral and 27% bilateral. For the patients who had bilateral disease formerly, 17% (n = 3) of them had recurrent bilateral disease. Conclusion. Allergic fungal rhinosinusitis is a distinct clinical entity. A high recurrence rate is a pathognomonic feature of the disease, despite all the development in medical and surgical trials. This study demonstrated that recurrence rate is lower in our population. However, more studies with a greater number of patients are needed in the future to clearly recognize the pattern of recurrence in patients with AFRS.

Download Full-text

Role of Fungi in Allergic Fungal Sinusitis and Chronic Rhinosinusitis hinosinnsitis

Mayo Clinic Proceedings ◽

10.1016/s0025-6196(11)64228-6 ◽

2000 ◽

Vol 75 (5) ◽

pp. 540 ◽

Cited By ~ 2

Author(s):

Stephen Naylor

Keyword(s):

Chronic Rhinosinusitis ◽

Fungal Sinusitis ◽

Allergic Fungal Sinusitis

Download Full-text

Role of Fungi in Allergic Fungal Sinusitis and Chronic Rhinosinusitis hinosinnsitis

Mayo Clinic Proceedings ◽

10.4065/75.5.540 ◽

2000 ◽

Vol 75 (5) ◽

pp. 540

Author(s):

Stephen Naylor

Keyword(s):

Chronic Rhinosinusitis ◽

Fungal Sinusitis ◽

Allergic Fungal Sinusitis

Download Full-text

Prevalence of Allergic Fungal Sinusitis in Refractory Chronic Rhinosinusitis in Adult Malaysians

Otolaryngology ◽

10.1016/j.otohns.2005.03.028 ◽

2005 ◽

Vol 133 (1) ◽

pp. 27-31 ◽

Cited By ~ 20

Author(s):

Bee-See Goh ◽

Balwant Singh Gendeh ◽

Isa Mohamed Rose ◽

Sabiha Pit ◽

Shamim Abdul Samad

Keyword(s):

Chronic Rhinosinusitis ◽

Immunoglobulin E ◽

Cross Sectional Study ◽

Fungal Sinusitis ◽

Allergic Fungal Sinusitis ◽

Cross Sectional ◽

Positive Skin ◽

Identification Of Fungi ◽

Aspergillus Sp ◽

Fungal Allergen

OBJECTIVE: To determine the prevalence of allergic fungal sinusitis (AFS) in refractory chronic rhinosinusitis (CRS) in adult Malaysians. STUDY DESIGN AND SETTING: This cross-sectional study involved 30 immunocompetent CRS patients who underwent surgery. Specimens were sent for mycology and histopathologic analysis for identification of fungi. Clinical and immunological workup was performed for atopy in all patients and controls. RESULTS: Fungal cultures were positive in 5 (16.7%) and 11 (36.7%) of 30 patients from nasal secretions and surgical specimens, respectively. Allergic mucin was found in 8 surgical specimens (26.7%). Hence, prevalence of AFS was 26.7%. The most common causative agent was Aspergillus sp. (54.5%). In 3 (37.5%) of 8 patients, AFS was found to be associated with asthma. Twenty-five percent (2/8 patients) had aspirin intolerance, and 62.5% (5/8 patients) had elevated total immunoglobulin E levels. All patients had positive skin test reactivity to fungal allergen. CONCLUSIONS: This preliminary study suggests that AFS does exist in Malaysia. Proper handling of surgical specimens and accurate diagnosis by the pathologist and mycologist are essential.

Download Full-text

Oral Corticosteroid Prescribing Habits for Rhinosinusitis: The American Rhinologic Society Membership

American Journal of Rhinology and Allergy ◽

10.2500/ajra.2017.31.4396 ◽

2017 ◽

Vol 31 (1) ◽

pp. 22-26 ◽

Cited By ~ 9

Author(s):

John R. Scott ◽

Hannah M. J. Ernst ◽

Brian W. Rotenberg ◽

Luke Rudmik ◽

Leigh J. Sowerby

Keyword(s):

Chronic Rhinosinusitis ◽

Respiratory Disease ◽

Average Duration ◽

Fungal Sinusitis ◽

Allergic Fungal Sinusitis ◽

Prescribing Habits ◽

Not Otherwise Specified ◽

Aspirin Exacerbated Respiratory Disease ◽

Starting Dose ◽

Acute Bacterial Rhinosinusitis

Background In the field of otolaryngology, oral corticosteroids (OCS) are widely prescribed for rhinosinusitis. Although there is evidence in the literature regarding specific OCS dosing protocols, it is not known to what extent these recommendations are being followed. Objective To examine the current state of OCS prescribing habits for rhinosinusitis by American Rhinologic Society members. Methods An anonymous online survey was sent to all American Rhinologic Society members. Dosing, frequency, tapering, and overall prescribing habits for OCS were assessed in chronic rhinosinusitis with polyposis (CRSwP) and in chronic rhinosinusitis without polyposis and acute bacterial rhinosinusitis. The CRSwP group was subdivided into aspirin-exacerbated respiratory disease, allergic fungal sinusitis, and not otherwise specified. Results were compared with current guidelines. Descriptive statistics were used to analyze data. Results Ninety-three surveys were completed (response rate, 12.9%). Prednisone was the most common OCS prescribed. In the CRSwP-aspirin-exacerbated respiratory disease group (n = 86), the median starting dose was 60 mg (range, 4-80 mg) and the average duration was 8 days (range, 2-28 days). In the CRSwP-allergic fungal sinusitis group (n = 81), the median starting dose was 50 mg (range, 20-60 mg), and the average duration was 6 days (range, 2-35 days). In the CRSwP-not otherwise specified group (n = 84), the median starting dose was 50 mg (range, 20-80 mg) and the average duration was 5 days (range, 1-21 days). OCS were prescribed for chronic rhinosinusitis without polyposis and acute bacterial rhinosinusitis by 66.0 and 62.4% of respondents, respectively. Conclusion Significant heterogeneity existed in OCS prescribing habits for rhinosinusitis. Discrepancies were observed between survey results and evidence-based recommendations. Developing standardized OCS treatment protocols for rhinosinusitis may improve the quality of care by optimizing clinical outcomes and reducing the risk of complications.

Download Full-text